The successful management of hypertension requires an active involvement of physicians. We studied trends in Finnish physicians' opinions about the management of hypertension between 1985 and 1992. The response rates in these two random samples of physicians were 68% and 56%, respectively. Physicians who reported regularly treating hypertensive patients were included in our analyses (n 1 = 319, n 2 = 470).
Introduction
In the 1980s and 1990s the guidelines for the management of hypertension have become more aggressive in Finland and also internationally. Pharmacological as well as non-pharmacological treatment is today recommended to be started at lower levels of blood pressure (BP) than before and the target BP of the treatment has also decreased. 1 A growing amount of new information has also accumulated about the benefits of treating elderly patients for hypertension. 2 At the same time several new antihypertensive agents have become available. Especially angiotensin-converting enzyme (ACE) inhibitors and calcium channel (Ca)-blockers have rapidly increased their share of the sales among antihypertensive agents. 3 However, concern has risen due to the relatively high cost of treatment with these new drugs. 4, 5 There are reports from different countries describing the therapeutic traditions of anti-hypertensive treatment during the last decade. [6] [7] [8] [9] Yet, little information is available as to how the availability of these new anti-hypertensive drugs and consensus statements for treating patients with high BP have influ- The choice of drugs for anti-hypertensive therapy changed drastically from 1985 to 1992. For younger patients ACE inhibitors became the drug of choice and for older patients Ca-blockers gained popularity from diuretics. A similar shift can also be seen in the sales statistics. Whether this increased activity in starting drug therapy and using new drugs will improve the outcome of treatment remains to be seen.
enced the actual prescribing behaviour of the physicians.
The purpose of this study was to analyse the changes in physicians' opinions about the treatment of hypertension in Finland in the 7-year period from 1985 to 1992.
Materials and methods
A self-administered postal questionnaire was sent to a random sample of Finnish physicians in December 1985 and in May 1992. Physicians (n = 825) from different geographical areas were included in 1985. In 1992 two new areas were added with a total sample of 1776 physicians. Names and addresses were collected from the files of the Finnish Medical Association which comprises about 95% of physicians who are licenced to practice in Finland. Because the forms were not identifiable all the doctors received a second mailing. The response rates were moderate: 68% in 1985 and 56% in 1992. In our analyses physicians who reported regularly treating hypertensive patients were included (n 1 = 319, n 2 = 470). The only exclusion criterion was not caring for hypertensive patients by respondents own statement.
The general characteristics (age, gender and specialisation) of all respondents agree with all Finnish physicians both in 1985 and in 1992 (data not shown). Physicians who treat hypertensive patients were slightly younger than all the other physicians and they were more often female and not specialised. In 1992 42% of all respondents were female and 45% of those who treat hypertensive patients. The corresponding figures of specialists were 54% and 43%, respectively.
The majority of questions were identical in both surveys. The questionnaire was based on an earlier international study comparing therapeutic traditions in Sweden, Norway and Northern Ireland. 6 The physicians were asked about their background data, practice details and their own health-related lifestyles as well as their opinions on treating diabetes and hypertension. Also questions on nonpharmacological measures were included in the survey. Additionally questions dealing with the initiation of treatment for some specific age groups and for particular case patients were presented.
The data were analysed with the SPSS/PC+ program. The Student's t-test was used for differences in means and the 2 test for differences in categorical variables.
Results

Initiation of pharmacological treatment
The reported level of diastolic BP for starting antihypertensive drug treatment for a middle-aged man (no specific age given) varied to a large extent in both surveys. The mean level, however, decreased significantly from 103 ± 5 (s. anti-hypertensive drug treatment rose from 168 ± 12 mm Hg in 1985 to 169 ± 13 mm Hg in 1992 (P = 0.098). For systolic BP the mode was 160 mm Hg in both years, 31% and 32% of physicians used this threshold for initiating drug treatment in 1985 and in 1992 respectively. Cumulative figures were also disappointing. At a systolic BP of 160 mm Hg, 45% of physicians would have started drug treatment in 1985 but only 42% in 1992 (Figure 2 ).
Goal level of blood pressure
There was a downward trend in the goal level of diastolic BP. In 1985, the mean was 90 ± 5 mm Hg and it decreased to 89 ± 4 mm Hg in 1992 (P Ͻ 0.001). In 1985, 70% of respondents tried to achieve diastolic BP at or below 90 mm Hg while in 1992 their share was 88% (Figure 3) . The mean of the goal for systolic BP was 147 mm Hg and mode 140 mm Hg in both years. Cumulative percentages were also almost identical. In both years 45% of physicians tried to achieve a systolic BP at or below 140 mm Hg.
The influence of gender and age of the patient
There was a tendency to start drug treatment in younger patients and in men more actively than in women and elderly patients. Diastolic BP levels reported by physicians for starting drug treatment decreased in all age and sex groups between 1985 and 1992 ( Table 1 ).
Drug of choice for different patients
There was a marked change in the choice of antihypertensive agents between 1985 and 1992. Altog- Figure 2 The level of systolic BP (mm Hg) used by physicians to start anti-hypertensive drug treatment for a middle-aged man, percentage of answers. ether 87% of the physicians used a diuretic as the first choice for a patient over 75 years of age in 1985, but in 1992 this proportion was only 60% (Figure 4) . For patients aged 60-75 years the drop was even bigger, from 83% to 35% and in this age group Cablockers gained much popularity during this period.
For patients under 45 years of age the choice of beta-blockers decreased from 87% to 37%. In this age group an ACE inhibitor became the drug of choice with a share of 49% in 1992. For the age group 45-60 years a similar decrease in the use of beta-blockers occurred, but the increase in the use of Ca-blockers was somewhat higher than in the youngest age group.
Changes in non-pharmacological care
Physicians were asked which of the non-pharmacological measures they applied in treating their hypertensive patients. The overall activity in nonpharmacological measures increased to some extent but a considerable gap for improvement was still left. The most important means for non-pharmacological advice for hypertensive patients remained the same: weight reduction and anti-smoking advice ( Table 2 ). Exercise and fat restriction especially have become more popular (P Ͻ 0.001) but only a little over half of the physicians advise these measures to all their hypertensive patients.
Discussion
This study showed that the opinions of Finnish physicians have changed which is possibly due to the new evidence of the benefits of more active hypertension management. 10 Even though the reported levels of diastolic BP for starting antihypertensive drug treatment were significantly lower in 1992 than in 1985 they were still higher than that reported from some other countries, for example 95 mm Hg in New Zealand. 8 Physicians have also adopted lower goals of diastolic BP. At the same time the level of systolic BP physicians used as a threshold to initiate drug treatment and as a goal level for treatment remained unchanged from 1985 to 1992. The BP levels for starting drug treatment even rose with the increasing age of the patient as has been also reported in Great Britain. 11 These results raise questions about the physicians' seriousness in the involvement in the management of hypertension. It seems that easy solutions to improve treatment have been primarily sought from switching from traditional to new anti-hypertensive agents possibly due to quality of life motives without having any clear aim in BP levels.
Physicians have become more interested in nonpharmacological care which is very pleasing. In this report Finnish physicians still seem to be less demanding than, for example, their Canadian colleagues. 12 We also do not know how systematically these measures are implemented in the actual hypertension care.
The most prominent difference in the reported hypertension care between 1985 and 1992 is the growth of the popularity of new anti-hypertensive agents. ACE inhibitors in particular have become widely used as drugs of first choice. This finding is supported by the consumption statistics of drugs. 3 Similar findings have been reported from many different countries, but there are still many differences in the popularity of ACE inhibitors and Ca-blockers between nations. 5, 7, 8, 13, 14 In principle, it can be a good sign if physicians follow new developments in their area of patient care. The case of a rapid move from well-evaluated, relatively inexpensive and safe anti-hypertensive drugs such as diuretics and beta-blockers to newer, more expensive and less evaluated anti-hypertensives such as Ca-blockers and ACE inhibitors as the first line treatment has been criticised by many experts. These newer drugs were also recommended by the US Joint National Committee as first line drugs in 1988, 15 but this recommendation was later withdrawn in 1993. 16 Recently, there has been extensive discussion about the safety of certain Cablockers in the long term use. [17] [18] [19] On the other hand, we should keep in mind that mass treatment of hypertension has been practiced only during the past 20-25 years. Thus, treatment traditions have only been initiated along with new pharmacological developments. Primary care physicians may find it difficult to follow the best treatment practice when even the leading researchers in the field have major arguments in favour and against different treatment strategies.
Some reservations have to be made since therapeutic traditions measured by a questionnaire do not necessarily need to match with the actual patient care. The reported behaviour tends to be more ideal compared with the everyday practice. Also the moderate response rates of this study may influence the results, even though the sample is adequate and there are no significant differences between all Finnish physicians and the sample as regard to age and gender.
We conclude that the increasing popularity of the new drugs is of concern, because of the high cost of these anti-hypertensive agents and the lack of prospective reports of their impact on the morbidity and the mortality of hypertensive patients. Can we achieve a better control and outcome of hypertension in the population with this new expensive therapeutic tradition?
